Australia's largest stock trading and investment forum Australia's #1 stock forum

IBX

Click for more information

0.00%

7.4¢ imagion biosystems limited

Ann: First-in-human study update - First patient enrolled, page-56

First 56 Last

Share
Profile

Follow
mike999

2,379 Posts.

717

26/05/21

14:08

Post #: 53429115
Share

Originally posted by ainsleym: ↑

I think it would be fair to say that should the first patient trial go well, with proof-of-concept of the technology, then some kind of announcement would be made, with the obvious caveat stated that nothing can be definitive until the full cohort of enrollees has been trialled. But just getting that first result will have a significant impact. Without going back through all the reports, and the ANZCTR document, which documents the the trial protocol, if not mistaken a single person trial extends over a couple of weeks only. The first MRI scans are done I think after 2 days from innoculation of the Magsense nanoparticles.

Expand

Spot on. Timelines on the results are short once injected but the question is will they release results after one candidate?
My opinion is yes with the usual qualifying criteria.

We know it has worked in lab mouse models so the outcome here is keenly awaited.
Topped up with a few more today.

IBX Price at posting: 12.5¢ Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

There are more pages in this discussion • 474 more messages in this thread...

First 56 Last

Add IBX (ASX) to my watchlist